Mirko Beljanski Extracts

Synergetic Anticancer Activities

Beljanski’s Pao pereira extract (Geissospermum vellosii)

extract
Mirko Beljanski, while working at the Pasteur Institute in Paris, was the first to investigate the anticancer activity of Pao pereira as an extract that would be effective against cancer cells, but not penetrate healthy cells. He published several publications on the anticancer effect of this extract, all dedicated to its efficiency and selectivity of action.
Learn more about Pao pereira

 

Rauwolfia vomitoria

Beljanski's Rauwolfia vomitoria extract

Dr. Beljanski perfected an extract standardized in alstonine, but devoid of reserpine. Beljanski noted that once reserpine was removed from the Rauwolfia vomitoria extract, the extract had a selective effect against cancer cells with very low toxicity and no effect on hypertension.
Learn more about Rauwolfia vomitoria

 
 

Support Along With Traditional Treatments

Golden Leaf of Ginkgo biloba

Beljanski's Golden leaf of Ginkgo Biloba extract

Some highly beneficial aspects of this extract include: regulation of nucleases (pathology and chemotherapy change a cell’s nucleus quantitatively and qualitatively); protection from side effects of gamma radiation (powerful protective element against various side effects including fibrosis), the protection of chromosomes; and a positive effect on the liver.
Learn more about golden leaf Ginkgo biloba

 
 

Beljanski’s RNA Fragments

RNA fragments stimulate the formation of white blood cells and platelets. Mirko Beljanski discovered that they not only help maintain normal white blood cell and platelet levels, which may decrease to dangerously low levels in a number of situations including radiation therapy and chemotherapy, but they also preserve normal proportions among the various kinds of white blood cells, notably those that fight infections.
Learn more about RNA Fragments

 

Where to find Mirko Beljanski’s Extracts

The Beljanski Foundation does not sell any of Mirko Beljanski’s extracts.
Natural Source International, Ltd. is the only company to own the patents developed by Mirko Beljanski, PhD, and respects the extraction methods and the quality defined by this renowned scientist.